title: Novel naphthalimide polyamine derivatives as potential antitumor agents.
abstract: A novel series of naphthalimide polyamine conjugates were designed, synthesized and evaluated for in vitro antiproliferative activity against human leukemia (Jurkat), human cervical adenocarcinoma (HeLa), human breast adenocarcinoma (MCF-7) and human lung adenocarcinoma (A549) cell lines. From the six derivatives, the new I1 and A3 exhibited highest antiproliferative activity with the IC50 values of 5.67-11.02 μmol · L(-1). Cell cycle analysis of Jurkat cells exposed to I1 at a concentration of 30 μmol × L(-1) for 24 h exhibited a mild increase in S and G2/M fraction caused by accumulation of cells. This arrest was followed by an increase in sub-G0/G1 after 48 h of incubation. Jurkat cells exposed to A3 at a concentration of 30 μmol × L(-1) for 24 h showed an increase in G0/G1 fraction and after 48 h an increase in G2/M fraction followed by an increase in sub-G0/G1 after 72 h of incubation. Moreover, the A3 compound was observed to displace the intercalating agent ethidium bromide from calf thymus DNA using fluorescence spectroscopy. The apparent binding constant was estimated to be 3.1 × 10(6) M(-1) what indicates non-intercalating mode of DNA binding. On the other hand, we found no inhibitory effect of studied compounds on topoisomerase I and topoisomerase II activity. Finally, the localization of these compounds in the cells due to their inherent fluorescence was investigated with the fluorescence microscopy. Our results suggest that the naphthalimide polyamine conjugates rapidly penetrate to the cancer cells. Further studies are necessary to investigate the precise mechanism of action and to find out the relationship between the structure, character and position of substituents of naphthalimide polyamine conjugates and their biological activities.
authors: Department of Pharmacology, Faculty of Medicine, University of Pavol Jozef Safarik, Trieda SNP 1, 040 66, Kosice, Slovakia.
authors: Robert
authors: R
authors: Seliga
authors: Martina
authors: M
authors: Pilatova
authors: Marek
authors: M
authors: Sarissky
authors: Viktor
authors: V
authors: Viglasky
authors: Martin
authors: M
authors: Walko
authors: Jan
authors: J
authors: Mojzis
mesh_terms: D000818:Animals; D000970:Antineoplastic Agents / Q000737:chemistry / Q000494:pharmacology*; D002417:Cattle; D002453:Cell Cycle / Q000187:drug effects; D045744:Cell Line, Tumor; D049109:Cell Proliferation / Q000187:drug effects; D004247:DNA / Q000378:metabolism; D004354:Drug Screening Assays, Antitumor; D004996:Ethidium / Q000378:metabolism; D005453:Fluorescence; D006801:Humans; D053644:Naphthalimides / Q000737:chemistry / Q000494:pharmacology*; D011073:Polyamines / Q000737:chemistry / Q000494:pharmacology*
chemical_list: D000970:Antineoplastic Agents; D053644:Naphthalimides; D011073:Polyamines; D004247:DNA; C427203:calf thymus DNA; D004996:Ethidium
references: Neoplasia. 2009 Nov;11(11):1226-34
references: 19881958
references: Neoplasia. 2008 Jun;10(6):573-86
references: 18516294
references: Bioorg Med Chem. 2009 Jan 1;17(1):13-24
references: 19058969
references: Cell Mol Life Sci. 2001 Feb;58(2):244-58
references: 11289306
references: J Med Chem. 2002 Dec 19;45(26):5813-6
references: 12477366
references: Mol Cancer Ther. 2007 Feb;6(2):484-95
references: 17308047
references: Org Biomol Chem. 2003 Feb 21;1(4):648-54
references: 12929451
references: Org Biomol Chem. 2004 Mar 21;2(6):915-21
references: 15007422
references: Nucleic Acids Res. 1995 Jan 25;23(2):223-9
references: 7862525
references: J Med Chem. 2009 Dec 10;52(23):7873-7
references: 19954251
references: Curr Med Chem. 2009;16(10):1192-213
references: 19355879
references: Bioorg Med Chem. 2007 Aug 1;15(15):5114-21
references: 17532640
references: Eur Biophys J. 2010 Jul;39(8):1243-9
references: 20135310
references: Biochem Pharmacol. 2005 Jan 1;69(1):19-27
references: 15588710
references: Nucleic Acids Res. 1979 Oct 10;7(3):547-69
references: 41222
references: J Immunol Methods. 1983 Dec 16;65(1-2):55-63
references: 6606682
references: Cancer Res. 1999 Jun 1;59(11):2557-61
references: 10363972
references: Biochemistry. 1995 Aug 8;34(31):9962-76
references: 7632695
references: Chem Biol Interact. 2001 Jul 31;137(1):15-24
references: 11518561
references: Biochemistry. 1993 Apr 27;32(16):4237-45
references: 8476851
references: J Biochem. 2006 Jan;139(1):27-33
references: 16428316
references: J Med Chem. 2004 Mar 11;47(6):1391-9
references: 14998328
references: J Med Chem. 2007 Aug 23;50(17):4122-34
references: 17658777
references: J Inorg Biochem. 2003 Jul 1;95(4):334-42
references: 12818804
references: Eur J Med Chem. 2009 Jan;44(1):393-9
references: 18423800
references: Clin Cancer Res. 2003 Jul;9(7):2769-77
references: 12855657
references: J Clin Oncol. 2001 Feb 1;19(3):857-69
references: 11157040
references: J Med Chem. 2004 Apr 22;47(9):2236-42
references: 15084122